Know Your IPO: GoodRx, Digging Into Nike's Earnings & Anaplan CEO
The Dow closed down 525 points, swinging 680+ points, and Jim Cramer is helping investors navigate the ongoing bear market. Then, as the wave of public offerings continues, Cramer's taking a closer look at today's IPO GoodRx and how it might fit into your portfolio. Next, as the aftershocks of Nike's…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.